No Evidence for a Major Gene Effect of the Dopamine D4 Receptor Gene in the Susceptibility to Gilles de la Tourette Syndrome in Five Canadian Families

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 3, 1996, Pages 301-305

  Barr, Cathy L ^a,b   Wigg, Karen G ^a   Zovko, Elizabeth ^b   Sandor, Paul ^b   Tsui, Lap Chee ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dopamine D4 receptor; Genetics; Gilles de la Tourette Syndrome

Indexed keywords

DOPAMINE 4 RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CANADA; CHILD; CLINICAL FEATURE; DOPAMINERGIC SYSTEM; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAJOR GENE; MALE; PRIORITY JOURNAL; TIC;

CANADA; EXONS; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SEQUENCE DELETION; TOURETTE SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 0029931471     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960531)67:3<301::AID-AJMG6>3.0.CO;2-P     Document Type: Article

References (36)

1. American Psychiatric Association (1987): "Diagnostic and Statistical Manual of Mental Disorders," Third Edition, Revised. Washington, D.C.: American Psychiatric Association.
2. Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS (1979): Biogenic amine metabolism in Tourette syndrome. Ann Neurol 6: 37-39.
3. 4 receptor gene in psychotic patients. Biol Psychiatry 34:459-464.
4. Clerget-Darpoux F, Bonaiti-Pellie C, Hochez J (1986): Effects of misspecifying genetic parameters in lod score analysis. Biometrics 42: 393-399.
5. Cohen DJ, Shaywitz BA, Caparulo BK, Young JG, Bowers MB (1978): Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 35:245-250.
6. Derogatis LR (1977): SCL-90: "Administration, Scoring and Procedures Manual-I: Clinical Psychometric Research." Baltimore: Johns Hopkins University School of Medicine.
7. Edwards A, Hammoned HA, Jin L, Caskey CT, Chakraborty R (1992): Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12: 241-253.
8. Frankel M, Cummings JL, Robertson MM, Trimble MR, Hill MA, Benson DF (1986): Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology 36:378-382.
9. Gelernter J, Kennedy JL, van Tol HHM, Civelli O, Kidd KK (1992): The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics 13:208-210.
10. Gelernter J (1995): DRD4 Alleles are associated with Tourette's syndrome. Psychiat Gene 5:S20.
11. Golden GS (1988): The use of stimulants in the treatment of Tourette's syndrome. In Cohen DJ, Bruun RD, Leckman JF (eds): "Tourette's Syndrome and Tic Disorders. Clinical Understanding and Treatment." New York, NY: John Wiley and Sons, pp 317-325.
12. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989): The Yale-Brown obsessive compulsive scale. Arch Gen Psychiatry 46:1006-1011.
13. Goyette C, Conners C, Ulrich R (1978): Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 6:221-236.
14. Haldane JBS (1919): The combination of linkage values and the calculation of distances between the loci of linked factors. J Genet 8:299-309.
15. Jankovic J, Glaze DG, Frost JD (1984): Effects of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology 34: 688-692.
16. Kurlan R (1989): Tourette's syndrome: Current concepts. Neurology 39:1625-1630.
17. Lathrop GM, Lalouel JM, Julier C, Ott J (1985): Multilocus linkage analysis in humans: Detection of linkage and estimation of recombination. Am J Hum Genet 37:482-498.
18. Leckman JF, Riddle MA, Cohen DJ (1988): Pathobiology of Tourette's Syndrome. In Cohen DJ, Bruun RD, Leckman JF (eds): "Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment." New York, NY: John Wiley and Sons, pp 103-116.
19. Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ (1993): A hypervariable segment in the human dopamine receptor D4 (DRD4) Gene. Hum Mol Genet 2:767-773.
20. Miller SA, Dykes DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
21. Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H (1994): No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene. Am J Med Genet 54.361-364.
22. Nothen MM, Cichon S, Hemmer S, Hebebrand J, Remschmidt H, Lehmkuhl G, Poustka F, Schmidt M, Catalano M, Fimmers R, Korner J, Rietschel M, Propping P (1994): Human dopamine D4 receptor gene: Frequent occurrence of a null allele and observation of homozygosity. Hum Mol Genet 3:2207-2212.
23. Ott J (1974): Estimation of the recombination fraction in human pedigrees: Efficient computation of the likelihood for human linkage studies. Am J Hum Genet 26:588-597.
24. Pakstis AJ, Heutink P, Pauls DL, Kurlan R, van de Watering BJM, Leckman JF, Sandkuyl LA, Kidd JR, Breedveld GJ, Castiglione CM, Weber J, Sparkes RS, Cohen DJ, Kidd KK, Oostra BA (1991): Progress in the search for genetic linkage with Tourette Syndrome: An exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet 48:281-294.
25. Pauls DL, Hurst CR (1987): "Schedule for Tourette and Other Behavioral Syndromes," Version IV. New Haven, CT: Yale University Press.
26. Pauls DL, Pakstis AJ, Kurlan R, Kidd KK, Leckman JF, Cohen DJ, Kidd JR, Como P, Sparkes R (1990): Segregation and linkage analysis of Tourette's syndrome and related disorders. J Am Acad Child Adolesc Psychiatry 29:195-203.
27. Petronis A, VanTol HHM, Lichter JB, Livak KJ, Kennedy JL (1993): The dopamine D4 receptor gene maps on lip proximal to HRAS. Genomics 18:161-163.
28. Petronis A, O'Hara K, Kennedy JL, Barr CL, VanTol HHM (1994): (G)n-Mononucleotide polymorphism in the human D4 dopamine receptor (DRD4) gene. Hum Genet 93:719.
29. Pfeiffer C, Wagner ML (1994): Clozapine therapy for Parkinson's disease and other movement disorders. Am J Hospital Pharm 51: 3047-3053.
30. Seeman P. (1991): Brain dopamine receptors. Pharmacol Rev 32: 229-313.
31. Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT (1982): Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 12:361-366.
32. Sweet RD, Bruun RD, Shapiro E, Shapiro AK (1974): Presynaptic catecholamine antagonists as treatment for Tourette syndrome: Effects of alpha methylpara tyrosine and tetrabenazine. Arch Gen Psychiatry 31:857-861.
33. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610-619.
34. Van Tol HHM, Wu CM, Guan H-C, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V (1992): Multiple dopamine D4 receptor variants in the human population. Nature 358:149-152.
35. Ward PJ (1993). Some developments on the affected-pedigree-member method of linkage analysis (1993): Am J Hum Genet 52:1200-1215.
36. Weeks DE, Lange K (1988): The affected-pedigree-member method of linkage analysis. Am J Hum Gen 42:315-326.